Archive: 26/11/2012

New hope for setback-dogged cancer treatment

Several drugs companies have ineffectively tried to produce antibodies that bind to the IGF-1 receptor on the cell surface, which has a critical part to play in the development of cancer. Scientists at Karolinska Institutet ...

page 2 from 8